Actinobacteria are important producers of bioactive compounds. Extreme ecosystems cause evolution of novel secondary metabolic pathways of Actinobacteria and increase the possible discovery of new biological functions of bioactive compounds. Here, we isolated 65 Actinobacteria from rhizosphere soil samples of
Opuntia stricta
. An Actinobacteria strain (named SCA3-4) was screened against
Fusarium oxysporum
f. sp.
cubense
Tropical Race 4 (
Foc
TR4, ATCC 76255). The strain produced pink–white aerial mycelia and brown substrate mycelium on Gause No. 1 agar. Biverticillate chains of cylindrical spores were observed by scanning electron microscopy (SEM). Based on alignment of 16
S
rRNA sequences, a constructed phylogenetic tree showed that strain SCA3-4 shared a 99.54% similarity with
Streptomyces lilacinus
NRRL B-1968T. The morphological, biochemical, physiological, and molecular characteristics further indicated that strain SCA3-4 belongs to the
Streptomyces
sp. It can grow well on medium with the following antibiotics chloramphenicol, streptomycin, penicillin-G, gentamicin, erythromycin, nystatin or neomycin sulfate. The polymerase chain reaction (PCR) amplification of types I and II polyketide synthase genes (
PKS-I
and
PKS-II
) suggested its bioactive potential. Under treatment with 100 μg/ml of ethyl acetate extracts isolated from
Streptomyces
sp. SCA3-4, growth of
Foc
TR4 was inhibited and cell membrane was destroyed. Crude extracts also showed a broad-spectrum antifungal activity against 13 phytopathogenic fungi including
Foc
TR4 and displayed the lowest minimum inhibitory concentration (MIC) (0.781 μg/ml) against
Colletotrichum fragariae
(ATCC 58718). A total of 21 different compounds identified by gas chromatography–mass spectrometry (GC-MS) were composed of phenolic compound, pyrrolizidine, hydrocarbons, esters, and acids. Besides the known active compounds,
Streptomyces
sp. SCA3-4 possesses antimicrobial or other biological activities. Further attention will be paid on other compounds with no functional annotation, aiming at the discovery of new bioactive substances.